A 20-gene signature in predicting the chemoresistance of breast cancer to taxane-based chemotherapy. (Q51039907)

27 March 2018

title

A 20-gene signature in predicting the chemoresistance of breast cancer to taxane-based chemotherapy. (English)

1 reference

27 March 2018

1 reference

Dong-Xu He

1

1 reference

27 March 2018

Yu-Dong Xia

2

1 reference

27 March 2018

Xiao-Ting Gu

3

1 reference

27 March 2018

Jian Jin

4

1 reference

27 March 2018

Xin Ma

5

1 reference

27 March 2018

publication date

11 September 2014

1 reference

27 March 2018

published in

Molecular BioSystems

1 reference

27 March 2018

volume

10

1 reference

27 March 2018

issue

12

1 reference

27 March 2018

page(s)

3111-3119

1 reference

27 March 2018

Role of glutathione in cancer progression and chemoresistance

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00464G

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00464G

Genome-wide analysis of three-way interplay among gene expression, cancer cell invasion and anti-cancer compound sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00464G

Using a stem cell-based signature to guide therapeutic selection in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00464G

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00464G

Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00464G

A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00464G

MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00464G

Flexible covariate effects in the proportional hazards model

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00464G

Genomic signatures to guide the use of chemotherapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00464G

Taxane resistance in breast cancer: mechanisms, predictive biomarkers and circumvention strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00464G

Atg9 trafficking in autophagy-related pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00464G

Self-eating and self-killing: crosstalk between autophagy and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00464G

KLF6 induces apoptosis in prostate cancer cells through up-regulation of ATF3

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00464G

Regulator of G-protein signaling 19 (RGS19) and its partner Gα-inhibiting activity polypeptide 3 (GNAI3) are required for zVAD-induced autophagy and cell death in L929 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00464G

Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00464G

The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00464G

Cell motility: Golgi signalling shapes up to ship out.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00464G

Centrosome aberrations: cause or consequence of cancer progression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00464G

FGFR signaling promotes the growth of triple-negative and basal-like breast cancer cell lines both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00464G

FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00464G

Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00464G

Transcriptional regulation of cell polarity in EMT and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00464G

Asymmetric cell divisions promote Notch-dependent epidermal differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00464G

The epithelial-mesenchymal transition: new insights in signaling, development, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00464G

microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00464G

21 January 2018

Identifiers

DOI

10.1039/C4MB00464G

1 reference

27 March 2018

1 reference

27 March 2018